GMP FLT-3L, 50 UG, -GMP SCF, 50 UG, and GMP TPO, 50 UG.
Ended Purchase Order Awarded Last action
- Contract number
- 75N90021P00365
- Awardee
-
Cellgenix USA UEI CCYHJN1KNAM6
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,113
Award facts
- Contract value 100% obligated
- $17,112.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to Cellgenix USA for $17,112.96 on April 22, 2021, for GMP FLT-3L, GMP SCF, and GMP TPO reagents (50 micrograms each). Performance is scheduled in Germany with an ultimate completion date of April 30, 2021. The order is firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract 75N90021P00365?
75N90021P00365 was awarded to Cellgenix USA by NIH Clinical Center (National Institutes of Health) on April 22, 2021.
How much is contract 75N90021P00365 worth?
The government has obligated $17,113 on 75N90021P00365.
Was contract 75N90021P00365 competed?
The extent of competition for 75N90021P00365 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award